Table of Contents Author Guidelines Submit a Manuscript
International Journal of Genomics
Volume 2016, Article ID 7862962, 7 pages
http://dx.doi.org/10.1155/2016/7862962
Research Article

Clinical Application of a Modular Genomics Technique in Systemic Lupus Erythematosus: Progress towards Precision Medicine

1Division of Rheumatology, Medical University of South Carolina, Charleston, SC 29425, USA
2Center for Genomic Medicine, Medical University of South Carolina, Charleston, SC 29425, USA
3Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC 29425, USA
4Biogen Idec, Cambridge, MA 02142, USA
5Division of Rheumatology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA

Received 13 May 2016; Accepted 20 July 2016

Academic Editor: Brian Wigdahl

Copyright © 2016 Eric Zollars et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Pan, I. Amigues, S. Lyman et al., “A surge in anti-dsDNA titer predicts a severe lupus flare within six months,” Lupus, vol. 23, no. 3, pp. 293–298, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Stojan, H. Fang, L. Magder, and M. Petri, “Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity,” Lupus, vol. 22, no. 8, pp. 827–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. C. C. Mok, D. J. Birmingham, L. Y. Ho, L. A. Hebert, and B. H. Rovin, “High-sensitivity C-reactive protein, disease activity, and cardiovascular risk factors in systemic lupus erythematosus,” Arthritis Care & Research, vol. 65, no. 3, pp. 441–447, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C.-C. Liu, A. H. Kao, S. Manzi, and J. M. Ahearn, “Biomarkers in systemic lupus erythematosus: challenges and prospects for the future,” Therapeutic Advances in Musculoskeletal Disease, vol. 5, no. 4, pp. 210–233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Rus, S. P. Atamas, V. Shustova et al., “Expression of cytokine- and chemokine-related genes in peripheral blood mononuclear cells from lupus patients by cDNA array,” Clinical Immunology, vol. 102, no. 3, pp. 283–290, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. E. C. Baechler, F. M. Batliwalla, G. Karypis et al., “Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 5, pp. 2610–2615, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Bennett, A. K. Palucka, E. Arce et al., “Interferon and granulopoiesis signatures in systemic lupus erythematosus blood,” Journal of Experimental Medicine, vol. 197, no. 6, pp. 711–723, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Hardiman, “Microarray platforms—comparisons and contrasts,” Pharmacogenomics, vol. 5, no. 5, pp. 487–502, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. J. W. Bauer, M. Petri, F. M. Batliwalla et al., “Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study,” Arthritis and Rheumatism, vol. 60, no. 10, pp. 3098–3107, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Ashburner, C. A. Ball, J. A. Blake et al., “Gene ontology: tool for the unification of biology,” Nature Genetics, vol. 25, no. 1, pp. 25–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Subramanian, P. Tamayo, V. K. Mootha et al., “Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 43, pp. 15545–15550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Chaussabel, C. Quinn, J. Shen et al., “A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus,” Immunity, vol. 29, no. 1, pp. 150–164, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Banchereau, S. Hong, B. Cantarel et al., “Personalized immunomonitoring uncovers molecular networks that stratify lupus patients,” Cell, vol. 165, no. 6, pp. 1548–1550, 2016. View at Publisher · View at Google Scholar
  14. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 40, no. 9, article 1725, 1997. View at Google Scholar · View at Scopus
  15. M. Petri, M. Y. Kim, K. C. Kalunian et al., “Combined oral contraceptives in women with systemic lupus erythematosus,” The New England Journal of Medicine, vol. 353, no. 24, pp. 2550–2558, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Petri, D. Hellmann, and M. Hochberg, “Validity and reliability of lupus activity measures in the routine clinic setting,” The Journal of Rheumatology, vol. 19, no. 1, pp. 53–59, 1992. View at Google Scholar · View at Scopus
  17. A. S. Alvarado, A. Malvar, B. Lococo et al., “The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients,” Lupus, vol. 23, no. 8, pp. 840–847, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. N. E. Allaire, S. E. Bushnell, J. Bienkowska, G. Brock, and J. Carulli, “Optimization of a high-throughput whole blood expression profiling and its application to assess the pharmacodynamics of interferon (IFN) beta-1a or polyethylene glycol-conjugated IFN beta-1a in healthy clinical trial subjects,” BMC Research Notes, vol. 6, article 8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. GCRMA, Z. Wu, and R. Irizarry, “gcrma: Background Adjustment Using Sequence Information,” R package version 2.44.0, 2016.
  20. W. Huber, V. J. Carey, R. Gentleman et al., “Orchestrating high-throughput genomic analysis with Bioconductor,” Nature Methods, vol. 12, no. 2, pp. 115–121, 2015. View at Publisher · View at Google Scholar
  21. M. E. Ritchie, B. Phipson, D. Wu et al., “limma powers differential expression analyses for RNA-sequencing and microarray studies,” Nucleic Acids Research, vol. 43, no. 7, article e47, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Hastie, R. Tibshirani, B. Narashimhan, and G. Chu, Pam: Prediction Analysis for Microarrays, 2014.
  23. S. Davis and P. S. Meltzer, “GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor,” Bioinformatics, vol. 23, no. 14, pp. 1846–1847, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Iguyon and A. Elisseeff, “An introduction to variable and feature selection,” Journal of Machine Learning Research, vol. 3, pp. 1157–1182, 2003. View at Google Scholar · View at Scopus
  25. N. Singh, P. Traisak, K. A. Martin, M. J. Kaplan, P. L. Cohen, and M. F. Denny, “Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosus,” Arthritis Research and Therapy, vol. 16, article R165, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Chiche, N. Jourde-Chiche, E. Whalen et al., “Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures,” Arthritis & Rheumatology, vol. 66, no. 6, pp. 1583–1595, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Yuen, E. Wurmbach, R. L. Pfeffer, B. J. Ebersole, and S. C. Sealfon, “Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays,” Nucleic Acids Research, vol. 30, no. 10, article e48, 2002. View at Publisher · View at Google Scholar · View at Scopus